BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33688189)

  • 1. Hybrid Nanoparticles Modified by Hyaluronic Acid Loading an HSP90 Inhibitor as a Novel Delivery System for Subcutaneous and Orthotopic Colon Cancer Therapy.
    Pan C; Zhang T; Li S; Xu Z; Pan B; Xu S; Jin S; Lu G; Yang S; Xue Z; Chen P; Shen X; Wang F; Xu C
    Int J Nanomedicine; 2021; 16():1743-1755. PubMed ID: 33688189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
    Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
    BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysaccharide-modified nanoparticles with intelligent CD44 receptor targeting ability for gene delivery.
    Lin WJ; Lee WC
    Int J Nanomedicine; 2018; 13():3989-4002. PubMed ID: 30022822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors.
    Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC
    Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Suppression Efficacy of Heat Shock Protein 90 Inhibitor 17AAG in a Liposarcoma Mouse Model.
    Nam S; Kim H; Hong D; Park JB; Kim SJ
    Anticancer Res; 2017 Nov; 37(11):6291-6302. PubMed ID: 29061812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
    Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
    Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic Acid-Modified Cationic Lipid-PLGA Hybrid Nanoparticles as a Nanovaccine Induce Robust Humoral and Cellular Immune Responses.
    Liu L; Cao F; Liu X; Wang H; Zhang C; Sun H; Wang C; Leng X; Song C; Kong D; Ma G
    ACS Appl Mater Interfaces; 2016 May; 8(19):11969-79. PubMed ID: 27088457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
    Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
    Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation.
    Liu K; Wang ZQ; Wang SJ; Liu P; Qin YH; Ma Y; Li XC; Huo ZJ
    Int J Nanomedicine; 2015; 10():6445-54. PubMed ID: 26491300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models.
    Chung YL; Troy H; Banerji U; Jackson LE; Walton MI; Stubbs M; Griffiths JR; Judson IR; Leach MO; Workman P; Ronen SM
    J Natl Cancer Inst; 2003 Nov; 95(21):1624-33. PubMed ID: 14600095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
    Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
    J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
    Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J
    Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.
    Gao Z; Li Z; Yan J; Wang P
    Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44.
    Yang B; Mao Y; Zhang Y; Hao Y; Guo M; Li B; Peng H
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer.
    Choi KY; Jeon EJ; Yoon HY; Lee BS; Na JH; Min KH; Kim SY; Myung SJ; Lee S; Chen X; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
    Biomaterials; 2012 Sep; 33(26):6186-93. PubMed ID: 22687759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
    Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM
    Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer.
    Zajac M; Gomez G; Benitez J; MartĂ­nez-Delgado B
    BMC Med Genomics; 2010 Oct; 3():44. PubMed ID: 20920318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of HSP90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancer.
    Jia L; Yang H; Liu Y; Zhou Y; Li G; Zhou Q; Xu Y; Huang Z; Ye F; Ye J; Liu A; Ji C
    J Nanobiotechnology; 2024 Apr; 22(1):198. PubMed ID: 38649957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
    Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
    Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
    Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
    Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.